{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-084013","form_type":"8-K","ticker":"NMTC","cik":"0001500198","company_name":"NEUROONE MEDICAL TECHNOLOGIES Corp","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.276786+00:00","generated_at":"2026-06-08T14:45:23.890936+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"NeuroOne responds to FDA questions on OneRF Ablation System 510(k); expects feedback in 30 days","bullets":["Company responded to FDA questions on its 510(k) submission for the OneRF Ablation System.","FDA feedback expected within 30 days; commercialization targeted for H1 2024 pending clearance.","OneRF would be first sEEG-guided RF ablation system with real-time temperature control.","NeuroOne estimates worldwide brain ablation market at $100M+ with rapid growth potential.","CEO Dave Rosa cites potential to reduce hospital stays, procedures, and complications."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-084013","json":"https://secwatch.observer/filing/0001213900-23-084013.json","markdown":"https://secwatch.observer/filing/0001213900-23-084013.md","text":"https://secwatch.observer/filing/0001213900-23-084013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1500198/000121390023084013/0001213900-23-084013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1500198/000121390023084013/ea187820-8k_neuroone.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T14:45:23.890936+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}